- Home
- ESTC vs MDGL Comparison
ESTC vs MDGL Comparison
Compare ESTC & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESTC
- MDGL
- Stock Information
- Founded
- ESTC 2012
- MDGL 2011
- Country
- ESTC Netherlands
- MDGL United States
- Employees
- ESTC N/A
- MDGL N/A
- Industry
- ESTC Computer Software: Prepackaged Software
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- ESTC Technology
- MDGL Health Care
- Exchange
- ESTC Nasdaq
- MDGL Nasdaq
- Market Cap
- ESTC 9.4B
- MDGL 6.1B
- IPO Year
- ESTC 2018
- MDGL N/A
- Fundamental
- Price
- ESTC $87.12
- MDGL $417.43
- Analyst Decision
- ESTC Buy
- MDGL Strong Buy
- Analyst Count
- ESTC 27
- MDGL 10
- Target Price
- ESTC $120.75
- MDGL $474.67
- AVG Volume (30 Days)
- ESTC 2.5M
- MDGL 329.8K
- Earning Date
- ESTC 08-28-2025
- MDGL 10-30-2025
- Dividend Yield
- ESTC N/A
- MDGL N/A
- EPS Growth
- ESTC N/A
- MDGL N/A
- EPS
- ESTC N/A
- MDGL N/A
- Revenue
- ESTC $1,551,164,000.00
- MDGL $515,547,000.00
- Revenue This Year
- ESTC $14.61
- MDGL $394.12
- Revenue Next Year
- ESTC $12.53
- MDGL $57.74
- P/E Ratio
- ESTC N/A
- MDGL N/A
- Revenue Growth
- ESTC 17.43
- MDGL 3421.98
- 52 Week Low
- ESTC $70.15
- MDGL $200.63
- 52 Week High
- ESTC $118.84
- MDGL $457.16
- Technical
- Relative Strength Index (RSI)
- ESTC 54.69
- MDGL 54.19
- Support Level
- ESTC $85.70
- MDGL $418.36
- Resistance Level
- ESTC $89.91
- MDGL $440.90
- Average True Range (ATR)
- ESTC 3.56
- MDGL 13.63
- MACD
- ESTC 0.10
- MDGL -5.66
- Stochastic Oscillator
- ESTC 37.70
- MDGL 4.56
About ESTC Elastic N.V.
Elastic is a software company that specializes in AI-search, observability, and security deployments. Its search division offers both traditional keyword search and vector search methods to enable more context-aware querying. The software has open-source origins but generates revenue through valuable add-ons, including simplified data orchestration and server scaling techniques.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.